Blood
Age-adapted chemotherapy and MRD-oriented transplant for Ph-negative acute lymphoblastic leukemia: the GRAALL-2014 trial.
Nicolas Boissel, Sylvie Chevret, Françoise Rigal-Huguet, Thibaut Tl Leguay, Mathilde Hunault, Carlos Graux, Yves Chalandon, Eric Delabesse, Yosr Hicheri, Patrice Chevallier, Marie Balsat, Cedric Pastoret, Martine Escoffre-Barbe, Florence Pasquier, Magalie Joris
Published: 202510.1182/blood.2025029611
Abstract
The Group for Research in Adult Acute Lymphoblastic Leukemia (GRAALL)-2014 trial (ClinicalTrials.gov: NCT02617004, NCT02619630) evaluated an intensive, age-adapted protocol for adults aged 18-59 years with Philadelphia chromosome-negative acute lymph…
Preview only. Read the full abstract at the source